This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Stocks Owned by the Best Fund Managers (Update2)

(Story updated to add that Deutsche Bank reiterated its "buy" rating on Gilead Sciences, but lowered its price target to $57.)

BOSTON ( TheStreet) -- Although many of the best mutual fund managers were ultra-cautious late last year, they still made major commitments to select stocks, underscoring their confidence in the companies.

Research firm Morningstar, which tracks the portfolio changes of 26 top-performing mutual funds for its "Ultimate Stock-Pickers" series, published a list of 10 stocks those managers bought, either to establish a new position or to add to an existing one.

The stock pickers' choices were eclectic and, in one instance, surprising. The managers at the Fairfax Financial Holdings Fund (FRFHF) made a big addition to a conservative choice, the respected but underperforming health-care-products company Johnson & Johnson (JNJ - Get Report). At the same time, it added to its stake in the troubled Canadian mobile-device maker Research In Motion (RIMM).

The Yacktman Fund (YACKX) also bought Research In Motion shares, adding to its stake by more than 60% in the fourth quarter.

But the stock seeing the most buying was biotechnology firm Gilead Sciences (GILD - Get Report). The Hartford Capital Appreciation Fund (ITHAX) established a new position in it, buying nearly 4 million shares, while the Parnassus Equity Income Fund (PRBLX) doubled its stake, to 4 million shares, in the quarter.

Gilead also has the best ratings from analysts of the group, garnering 15 "buys." But last week, Deutsche Bank, while reiterating its "buy" rating on the firm's stock, lowered its price target to $57 from $66 on expectations of price discounts on its HPV drugs.

Parnassus bought a significant new stake in brokerage firm Charles Schwab (SCHW), picking up more than 10 million shares.

International banking firm Citigroup (C - Get Report) and the pharmaceuticals industry's biggest player, GlaxoSmithKline (GSK), were the only other companies to see two funds add to their positions in the period.

Also among the 26 fund managers on the Ultimate Stock-Pickers roster are the Dodge & Cox Stock Fund (DODGX) and Warren Buffett's Berkshire Hathaway (BRK.B).

"Managers send signals about the level of conviction they have in a position by how much of their portfolio (on a percentage basis) they're willing to commit to a given name at any point in time," Morningstar said in a research note. Although it found that the fourth quarter "was probably one of the least-active periods for stock buying that we've seen in quite some time."

Indicative of that, the top "buys" had only two of the 26 funds buying their shares, compared to prior periods when there were usually four of five managers buying a particular stock, Morningstar said.

Here are the 10 most-purchased stocks in the fourth quarter of 2011 by the "Ultimate Stock-Pickers" funds in order of value:
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
C $46.28 0.00%
DVN $34.68 0.00%
GILD $88.21 0.00%
JNJ $112.08 0.00%
AAPL $93.74 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs